Catalyst Wire Dossier Catalyst Wire Dossier

BV100

· BioVersys AG
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BV100, covering 2025-01-14 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex [Phase 2]

See pricing